To increase the cure rate for young people who have a cancer with a poor prognosis.
To increase the quality of life for survivors of childhood cancer.
The measure of success will be 10 years free of disease and late side effects.
The seven objectives (with equal importance and weight)
to introduce safe and effective innovative treatments (i.e. new
drugs, new technologies) into standard care.
Precision cancer medicine
to use improved risk classification as well as biological
characteristics of both the tumour and patient (such as molecular and immunological
factors) to help guide decisions on which therapies to use.
: to increase knowledge of tumour biology and speed up translation
from basic research to clinical care to benefit patients.
: to bring about equal access across Europe to standard care (in both
diagnosis and treatment), expertise and clinical research.
Teenagers and Young Adults
: to address the specific needs of teenagers and
young adults (TYA), in cooperation with adult oncology.
Quality of survivorship
: to address the consequences of cancer treatment such as long-
term side effects, to better understand the genetic background/risk of an individual, and
to improve quality of life of childhood cancer survivors.
Causes of cancer
: to understand the causes of paediatric cancers and to address
prevention wherever possible.
The overall goals over the next 10 years
A EUROPEAN CANCER PLAN FOR CHILDREN AND ADOLESCENTS